As Dana-Farber migrates its dozens of medical and radiation oncology protocols to the Philips platform, its focus is on digital pathology, genomics, and informatics.
The grant will support the consortium's ongoing efforts to clinically validate data analysis software for monitoring treatment responses to cancer vaccines.
The CATCH-KB database is a standardized variant repository meant to support new research into prevention of chemotherapy-induced cardiotoxicity.
Stand Up to Cancer is teaming with Microsoft and SITC to provide a new round of $11 million in grants to study cancer immunotherapies.
CEO Anders Rylander said the company will initially market its DiviTum assay for breast cancer cases, though it could be used to monitor cell proliferation in all cancer types.
The Belgian company recently received €3.6 million to develop the signature into a clinical test within the next three years.
The activity follows a recent financing round that has enabled OncoDNA to build out its sales team as it courts new clients.
The company is preparing a blood-based test for early-stage pancreatic cancer that it hopes to have on the market by 2019.
From targeted metagenomics on almost 300 soil samples, researchers saw evidence for microbiome gene clusters associated with natural product biosynthesis in NYC parks.
The partners will combine genome editing approaches with Watson's computational and machine learning methods to study drug-resistance in tumors.
This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.
The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.
Researchers find that people's genetics influence their success at university, but that it is not the only factor.
In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.